Organogenesis Holdings Inc ORGO:NASDAQ

Last Price$4.85Cboe Real-Time Last Sale as of 2:29PM ET 8/15/22
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change+0.13(2.75%)
Bid (Size)$4.84 (200)
Ask (Size)$4.85 (632)
Day Low / High$4.67 - 4.86
Volume540.9 K
 

View Biotechnology IndustryPeer Comparison as of 08/15/2022

 

Organogenesis Holdings Inc ( NASDAQ )

Price: $4.85
Change: +0.13 (2.75%)
Volume: 540.9 K
2:29PM ET 8/15/2022
 
 

Cara Therapeutics Inc ( NASDAQ )

Price: $11.72
Change: +0.21 (1.82%)
Volume: 126.8 K
2:26PM ET 8/15/2022
 
 

Ocugen Inc ( NASDAQ )

Price: $2.85
Change: +0.005 (0.18%)
Volume: 1.6 M
2:28PM ET 8/15/2022
 
 

Kodiak Sciences Inc ( NASDAQ )

Price: $11.94
Change: -0.26 (2.13%)
Volume: 431.1 K
2:30PM ET 8/15/2022
 
 

MaxCyte Inc ( NASDAQ )

Price: $5.74
Change: -0.13 (2.21%)
Volume: 96.6 K
2:22PM ET 8/15/2022
 

Read more news Recent News

Organogenesis Gets US FDA Clearance for PuraPly MZ Surgical Solution
8:27AM ET 8/15/2022 MT Newswires

Organogenesis (ORGO) said Monday that the US Food and Drug Administration has granted 510k clearance to its next-generation PuraPly MZ surgical solution....

Sector Update: Health Care Stocks Set to Finish Moderately Higher
3:55PM ET 8/10/2022 MT Newswires

Health care stocks remain moderately higher compared with most other sectors this afternoon, with the NYSE Health Care Index rising 0.6% while the SPDR...

Sector Update: Health Care Stocks Carried Higher with Broader Markets
1:16PM ET 8/10/2022 MT Newswires

Health care stocks were moderately higher compared with most other sectors this afternoon, with the NYSE Health Care Index rising 0.4% while the SPDR...

Organogenesis Shares Fall Wednesday After Company Reports Lower Q2 Financial Results, Cuts Fiscal 2022 Guidance
11:58AM ET 8/10/2022 MT Newswires

Organogenesis Holdings (ORGO) shares fell nearly 20% in Wednesday morning trading, a day after the company reported lower Q2 financial results and trimmed...

Company Profile

Business DescriptionOrganogenesis Holdings, Inc. is a regenerative medical company. It focuses on the development, manufacture and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. The company was founded in 1985 and is headquartered in Canton, MA. View company web site for more details
Address85 Dan Road
Canton, Massachusetts 02021
Phone+1.781.575.0775
Number of Employees700
Recent SEC Filing08/09/202210-Q
President, Chief Executive Officer & DirectorGary S. Gillheeney
Chief Operating OfficerPatrick R. Bilbo
Chief Financial OfficerDavid Charles Francisco
Vice President & General CounselLori H. Freedman

Company Highlights

Price Open$4.71
Previous Close$4.72
52 Week Range$4.62 - 17.50
Market Capitalization$634.8 M
Shares Outstanding130.9 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement11/08/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings8.58
Earnings per Share$0.56
Beta vs. S&P 500N/A
Revenue$193.4 M
Net Profit Margin15.83%
Return on Equity31.48%

Analyst Ratings as of 08/10/2022

Buy
1
Overweight
0
Hold
1
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset